Eurofins launches China Compulsory Certification Services for Toys Products
Eurofins Toys & Hardlines is pleased to announce that its laboratory in Hong Kong has received the China Compulsory Certification (CCC) for its toys testing service from Hong Kong Accreditation Service (HKAS), and launches the CCC certification services in cooperation with Certification Center of Light Industry Council (CCLC). This certification services cover both plastic and metal toys.
CCC is implemented by the Certification and Accreditation Administration of the People’s Republic of China (CNCA) to ensure safety for consumers in China. The certification programme covers a wide range of products, including children’s toys. All toys being imported to the Chinese market must fulfill the CCC requirements.
Eurofins’ new services offer a four-step certification process: application, testing, certification issuance and follow-up inspection. Throughout, the Eurofins team provides seamless project management, allowing customers to accelerate their entrance to the market.
According to the trade report from China Toy & Juvenile Products Association, sales of toys through the largest online B2C platform in China has recorded a robust year-on-year rise of 18.5% in August 2020, signalling a prosperous outlook for the toy industry in this booming market. Eurofins’ new offering will provide much needed assistance to overseas toys brands, retailers and suppliers in accessing this important market.
About Eurofins Toys & Hardlines
As part of the Eurofins Consumer Product Testing (CPT) Division, the Eurofins Toys & Hardlines network of companies (T&HL) delivers quality and safety solutions to the toys and hardgoods industry worldwide. Our expertise in toys and hardgoods products, complemented with global testing laboratories and professional teams, allows us to drive our customers to continuously improve their products and supply chain.
About Eurofins – a global leader in bio-analysis
Eurofins is Testing for Life. The Eurofins network of companies believes that it is a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, and in the support of clinical studies, as well as in biopharma contract development and manufacturing. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.
With ca. 62,000 staff across a network of over 900 laboratories in 62 countries, Eurofins offers a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
